| Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer SA Tomlins, DR Rhodes, S Perner, SM Dhanasekaran, R Mehra, XW Sun, ... science 310 (5748), 644-648, 2005 | 4906 | 2005 |
| Integrative clinical genomics of advanced prostate cancer D Robinson, EM Van Allen, YM Wu, N Schultz, RJ Lonigro, JM Mosquera, ... Cell 161 (5), 1215-1228, 2015 | 3968 | 2015 |
| The polycomb group protein EZH2 is involved in progression of prostate cancer S Varambally, SM Dhanasekaran, M Zhou, TR Barrette, C Kumar-Sinha, ... Nature 419 (6907), 624-629, 2002 | 3363 | 2002 |
| The mutational landscape of lethal castration-resistant prostate cancer CS Grasso, YM Wu, DR Robinson, X Cao, SM Dhanasekaran, AP Khan, ... Nature 487 (7406), 239-243, 2012 | 2822 | 2012 |
| Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer JS De Bono, HI Scher, RB Montgomery, C Parker, MC Miller, H Tissing, ... Clinical cancer research 14 (19), 6302-6309, 2008 | 2548 | 2008 |
| Delineation of prognostic biomarkers in prostate cancer SM Dhanasekaran, TR Barrette, D Ghosh, R Shah, S Varambally, ... Nature 412 (6849), 822-826, 2001 | 2155 | 2001 |
| Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone RS Taichman, C Cooper, ET Keller, KJ Pienta, NS Taichman, ... Cancer research 62 (6), 1832-1837, 2002 | 1333 | 2002 |
| Activating ESR1 mutations in hormone-resistant metastatic breast cancer DR Robinson, YM Wu, P Vats, F Su, RJ Lonigro, X Cao, ... Nature genetics 45 (12), 1446-1451, 2013 | 1244 | 2013 |
| Integrative molecular concept modeling of prostate cancer progression SA Tomlins, R Mehra, DR Rhodes, X Cao, L Wang, SM Dhanasekaran, ... Nature genetics 39 (1), 41-51, 2007 | 1105 | 2007 |
| Targeting the tumour stroma to improve cancer therapy KC Valkenburg, AE De Groot, KJ Pienta Nature reviews Clinical oncology 15 (6), 366-381, 2018 | 1035 | 2018 |
| Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets H Beltran, DS Rickman, K Park, SS Chae, A Sboner, TY MacDonald, ... Cancer discovery 1 (6), 487-495, 2011 | 1018 | 2011 |
| Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer SA Tomlins, B Laxman, SM Dhanasekaran, BE Helgeson, X Cao, ... Nature 448 (7153), 595-599, 2007 | 1013 | 2007 |
| Outcomes of observation vs stereotactic ablative radiation for oligometastatic prostate cancer: the ORIOLE phase 2 randomized clinical trial R Phillips, WY Shi, M Deek, N Radwan, SJ Lim, ES Antonarakis, SP Rowe, ... JAMA oncology 6 (5), 650-659, 2020 | 995 | 2020 |
| CXCL12/CXCR4/CXCR7 chemokine axis and cancer progression X Sun, G Cheng, M Hao, J Zheng, X Zhou, J Zhang, RS Taichman, ... Cancer and Metastasis Reviews 29 (4), 709-722, 2010 | 935 | 2010 |
| Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression S Varambally, J Yu, B Laxman, DR Rhodes, R Mehra, SA Tomlins, ... Cancer cell 8 (5), 393-406, 2005 | 907 | 2005 |
| α-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer MA Rubin, M Zhou, SM Dhanasekaran, S Varambally, TR Barrette, ... Jama 287 (13), 1662-1670, 2002 | 906 | 2002 |
| Temporal activation of p53 by a specific MDM2 inhibitor is selectively toxic to tumors and leads to complete tumor growth inhibition S Shangary, D Qin, D McEachern, M Liu, RS Miller, S Qiu, ... Proceedings of the National Academy of Sciences 105 (10), 3933-3938, 2008 | 841 | 2008 |
| Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing DR Robinson, YM Wu, S Kalyana-Sundaram, X Cao, RJ Lonigro, ... Nature genetics 45 (2), 180-185, 2013 | 829 | 2013 |
| Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrow Y Shiozawa, EA Pedersen, AM Havens, Y Jung, A Mishra, J Joseph, ... The Journal of clinical investigation 121 (4), 1298-1312, 2011 | 826 | 2011 |
| Identification of targetable FGFR gene fusions in diverse cancers YM Wu, F Su, S Kalyana-Sundaram, N Khazanov, B Ateeq, X Cao, ... Cancer discovery 3 (6), 636-647, 2013 | 813 | 2013 |
Arul Chinnaiyan確認したメール アドレス: umich.edu
